DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY Trademark

Trademark Overview

On Tuesday, July 18, 2023, a trademark application was filed for DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY with the United States Patent and Trademark Office. The USPTO has given the DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY trademark a serial number of 98090566. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, July 18, 2025. This trademark is owned by NanoVation Therapeutics Inc.. The DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY trademark is filed in the Pharmaceutical Products category with the following description:

Lipid-based delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of nucleic acid for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders associated with aging
delivering tomorrow's genetic medicines, today

General Information

Serial Number98090566
Word MarkDELIVERING TOMORROW'S GENETIC MEDICINES, TODAY
Filing DateTuesday, July 18, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, July 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesLipid-based delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of nucleic acid for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders associated with aging

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNanoVation Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBritish Columbia V6T1Z3
CA

Trademark Events

Event DateEvent Description
Friday, July 21, 2023NEW APPLICATION ENTERED
Wednesday, August 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 23, 2024ASSIGNED TO EXAMINER
Saturday, March 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 23, 2024NON-FINAL ACTION WRITTEN
Saturday, March 23, 2024NON-FINAL ACTION E-MAILED
Friday, June 14, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 23, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 14, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, September 23, 2024SUSPENSION LETTER WRITTEN
Monday, September 23, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, September 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 24, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, September 24, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 24, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, September 24, 2024SUSPENSION LETTER WRITTEN
Tuesday, September 24, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, March 25, 2025SUSPENSION INQUIRY WRITTEN
Tuesday, March 25, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, March 25, 2025INQUIRY TO SUSPENSION E-MAILED
Wednesday, July 9, 2025ASSIGNED TO LIE
Friday, July 18, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 18, 2025SUSPENSION LETTER WRITTEN
Friday, July 18, 2025LETTER OF SUSPENSION E-MAILED
Wednesday, July 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 25, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

today medicines genetic tomorrow delivering disorders lipid delivery diseases cancer infectious namely inflammation aging associated